Medtronic conducted a post market clinical follow-up (pmcf) survey to seek out potential new risks and assess the performance of medtronic¿s admiral xtreme pta balloon catheter.
Survey results received for an interventional cardiologist with 21 years¿ experience who was been using the admiral xtreme pta balloon catheter since 2019.
The respondent used 350 admiral xtreme devices since practicing, and 300 admiral xtreme in the last 12 months.
During use of the admiral xtreme pta balloon catheter, it was reported that the respondent experienced 8 dissection in the dilated artery wall events or complications associated with dilatation which were deemed somewhat concerning and related to device, and 2 perforation of the artery wall deemed very concerning and related to device.
|